D.A. Davidson & CO. increased its position in Heska Corporation (NASDAQ:HSKA) by 0.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,943 shares of the medical research company’s stock after buying an additional 5 shares during the period. D.A. Davidson & CO.’s holdings in Heska Corporation were worth $198,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Alps Advisors Inc. raised its position in shares of Heska Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 5,117 shares of the medical research company’s stock valued at $522,000 after buying an additional 14 shares during the last quarter. Louisiana State Employees Retirement System increased its position in Heska Corporation by 4.0% during the second quarter. Louisiana State Employees Retirement System now owns 2,600 shares of the medical research company’s stock worth $265,000 after purchasing an additional 100 shares during the last quarter. Victory Capital Management Inc. increased its position in Heska Corporation by 17.5% during the second quarter. Victory Capital Management Inc. now owns 1,133 shares of the medical research company’s stock worth $116,000 after purchasing an additional 169 shares during the last quarter. American International Group Inc. increased its position in Heska Corporation by 7.1% during the first quarter. American International Group Inc. now owns 3,754 shares of the medical research company’s stock worth $394,000 after purchasing an additional 248 shares during the last quarter. Finally, Teachers Advisors LLC increased its position in Heska Corporation by 4.0% during the fourth quarter. Teachers Advisors LLC now owns 9,493 shares of the medical research company’s stock worth $680,000 after purchasing an additional 364 shares during the last quarter. 81.36% of the stock is owned by institutional investors and hedge funds.

WARNING: “D.A. Davidson & CO. Has $198,000 Stake in Heska Corporation (HSKA)” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/10/06/d-a-davidson-co-has-198000-stake-in-heska-corporation-hska.html.

Heska Corporation (NASDAQ HSKA) opened at 96.44 on Friday. Heska Corporation has a 12 month low of $46.51 and a 12 month high of $115.00. The company’s 50-day moving average is $94.73 and its 200 day moving average is $98.32. The firm has a market cap of $696.88 million, a price-to-earnings ratio of 49.15 and a beta of 0.84.

Heska Corporation (NASDAQ:HSKA) last posted its quarterly earnings results on Thursday, August 3rd. The medical research company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $34.30 million during the quarter, compared to analyst estimates of $33.35 million. Heska Corporation had a net margin of 10.70% and a return on equity of 15.87%. The firm’s revenue was up 14.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.35 earnings per share. On average, equities research analysts predict that Heska Corporation will post $2.04 earnings per share for the current year.

In other news, EVP Nancy Wisnewski sold 825 shares of the stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $102.21, for a total value of $84,323.25. Following the completion of the sale, the executive vice president now directly owns 38,114 shares of the company’s stock, valued at $3,895,631.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John Mcmahon sold 2,608 shares of the stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $101.17, for a total transaction of $263,851.36. Following the completion of the sale, the chief financial officer now directly owns 193 shares of the company’s stock, valued at $19,525.81. The disclosure for this sale can be found here. 14.70% of the stock is owned by corporate insiders.

Several equities analysts recently commented on HSKA shares. Aegis upped their price target on shares of Heska Corporation from $114.50 to $129.50 and gave the stock a “buy” rating in a research report on Tuesday, August 1st. BidaskClub lowered shares of Heska Corporation from a “buy” rating to a “hold” rating in a research report on Sunday, July 16th. Zacks Investment Research raised shares of Heska Corporation from a “hold” rating to a “buy” rating and set a $109.00 price target for the company in a research report on Friday, August 4th. B. Riley reaffirmed a “neutral” rating and set a $85.00 price target on shares of Heska Corporation in a research report on Friday, July 28th. Finally, Benchmark Co. reaffirmed a “buy” rating and set a $120.00 price target (up previously from $106.00) on shares of Heska Corporation in a research report on Wednesday, August 9th. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $106.83.

Heska Corporation Profile

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Institutional Ownership by Quarter for Heska Corporation (NASDAQ:HSKA)

Receive News & Stock Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related stocks with our FREE daily email newsletter.